Lack of Benefit of Intravenous Synthetic Human Secretin in the Treatment of Autism.

The objective of this study was to determine if an intravenous infusion of synthetic human secretin improves language and behavioral symptoms in children with autism. Forty-two children with the diagnosis of autism were randomized to one of two groups in this double-blind cross-over trial. One group...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Autism & Developmental Disorders Vol. 32; no. 6; pp. 545 - 546
Autores principales: Molloy CA, Manning-Courtney P, Swayne S, Bean J, Brown JM, Murray DS, Kinsman AM, Brasington M, Ulrich CD II
Formato: clinical trial research Journal Article
Publicado: Springer Nature Dec2002
Acceso en línea:Ver este registro en EBSCOhost